The potential of multiparametric contrast-enhanced ultrasound to detect and predict sentinel lymph node status in invasive breast cancer
Open Access
- 28 March 2026
- journal article
- Published by Vidar, Ltd. in Medical Visualization
- Vol. 30 (1) , 68-80
Abstract
Axillary mapping and assessment of axillary lymph node status remains a key staging issue for determining treatment strategies and algorithms for patients with invasive breast cancer. Various ultrasound techniques (elastography, color Doppler, and SMI) are used to improve diagnostic accuracy. In recent years, ultrasound contrast agents have been widely adopted, increasing the diagnostic capabilities of ultrasound. The aim: to evaluate the diagnostic efficiency of CEUS and multiparametric ultrasound with the inclusion of the ultrasound contrast technique in preoperative detection and prediction of metastases in the SLN. Materials and methods. This study included a comprehensive analysis of data from 120 up-front patients with invasive breast cancer to evaluate the diagnostic value of qualitative (contrast patterns), quantitative, combined and multiparametric (combined CEUS parameters + B-mode) models. Results. Axillary lymph node metastases were detected in 29.2% of cases; the proportion of pN+ patients increased from patterns I–II to IV–V (up to 71–100%; p p < 0.001; AUC 0.84), transverse size and blood flow type in the color Doppler imaging mode had moderate information content ( p = 0.02 and p = 0.077, respectively). Integration of features improved accuracy: combined model – AUC 0.686, sensitivity – 60%, specificity – 81.2%, and multiparametric (combined with the addition of B-mode and color Doppler imaging) – the highest values (AUC 0.78; sensitivity 65.8%, specificity 80%). Conclusion. Intradermal paraareolar ultrasound injection of contrast agent provides a high rate of lymph node (SLN) identification and predict the status and metastatic burden of axillary lymph nodes. Multiparametric ultrasound, combining B-mode, color Doppler, and CEUS improves the diagnostic accuracy of axillary staging in patients with breast cancer.Keywords
This publication has 23 references indexed in Scilit:
- Multiparametric ultrasound assessment of axillary lymph nodes in patients with breast cancerScientific Reports, 2024
- The Value of Percutaneous Contrast‐Enhanced Ultrasound in Sentinel Lymph Node Identification, Metastatic Status and Burden Diagnosis in Early Breast CancerJournal of Ultrasound in Medicine, 2023
- Sentinel lymph node identification using contrast-enhanced ultrasound in breast cancer: review of the literatureJournal of Medical Ultrasonics, 2023
- Evaluation of whole axillary status with lymphatic contrast-enhanced ultrasound in patients with breast cancerEuropean Radiology, 2021
- Percutaneous contrast-enhanced ultrasound for localization and diagnosis of sentinel lymph node in early breast cancerScientific Reports, 2019
- Detection of sentinel lymph node using contrast-enhanced agent, Sonazoid™, and evaluation of its metastasis with superb microvascular imaging in oral and oropharyngeal cancers: a preliminary clinical studyActa Oto-Laryngologica, 2019
- Contrast-Enhanced Ultrasound-Guided Fine-Needle Aspiration for Sentinel Lymph Node Biopsy in Early-Stage Breast CancerUltrasound in Medicine & Biology, 2018
- Preoperative sentinel lymph node localization in vulvar cancer: preliminary experience with inguinal intradermal contrast-enhanced ultrasoundEuropean Radiology, 2017
- Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node MetastasisJAMA, 2017
- Sentinel lymph node localization with contrast-enhanced ultrasound and an I-125 seed: An ideal prospective development studyInternational Journal of Surgery, 2015